Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18674430 | INTEGRATED GAS FERMENTATION AND CARBON BLACK PROCESSES | May 2024 | June 2025 | Allow | 12 | 2 | 1 | No | No |
| 18659585 | MODIFIED PHI29 DNA POLYMERASES AND USES THEREOF | May 2024 | November 2024 | Allow | 6 | 1 | 1 | No | No |
| 18650206 | Improved transfection method using a Sleeping Beauty transposase variant with increased solubility that transfects a target cell when used in protein form | April 2024 | March 2025 | Allow | 11 | 2 | 1 | Yes | No |
| 18645049 | METHODS AND COMPOSITIONS FOR TREATMENT OF HUNTER SYNDROME COMPRISING IDURONATE-2-SULFATASE | April 2024 | February 2025 | Allow | 10 | 1 | 0 | No | No |
| 18632080 | Methods for Producing a Composition Containing Lipids From Recombinant Algae Having High Lipid Productivity | April 2024 | May 2025 | Allow | 13 | 2 | 0 | No | No |
| 18584254 | BIOFABRICATION OF ADVANCED FUNCTIONAL MATERIALS USING BACTERIAL CELLULOSE SCAFFOLDS | February 2024 | October 2024 | Allow | 7 | 0 | 0 | No | No |
| 18581247 | Method of Manufacturing Sugar Cane Polyvinyl Alcohol | February 2024 | March 2025 | Allow | 13 | 1 | 1 | No | No |
| 18440901 | Engineered Reverse Transcriptase Enzymes with Enhanced Enzymatic Activity in Nanoliter Reaction Volumes | February 2024 | January 2025 | Allow | 11 | 1 | 0 | No | No |
| 18439199 | ALGAL STRAIN AND METHODS FOR PRODUCING SIMPLE SUGARS | February 2024 | December 2024 | Allow | 10 | 1 | 0 | No | No |
| 18437294 | ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE CHROMATOGRAPHY RESINS | February 2024 | March 2025 | Allow | 13 | 1 | 1 | No | No |
| 18421170 | PRODUCTION OF FATTY ACYL-COA IN YEAST USING A FATTY ACID FEEDSTOCK | January 2024 | June 2025 | Allow | 17 | 2 | 0 | No | No |
| 18420071 | Polynucleotides Encoding Engineered Acetate Kinase Variant Enzymes | January 2024 | May 2025 | Allow | 16 | 1 | 1 | No | No |
| 18405043 | Host Cell Including Expression Vector for Encoding Catalysis Deactivated Angiotensin- Converting Enzyme 2 (ACE2) Variants | January 2024 | June 2025 | Allow | 17 | 2 | 1 | No | No |
| 18406057 | BIOSENSORS FOR DETECTING AND/OR NEUTRALIZING BIOAVAILABLE URANIUM AND RELATED U-SENSITIVE GENETIC MOLECULAR COMPONENTS, GENE CASSETTES, VECTORS, GENETIC CIRCUITS, COMPOSITIONS, METHODS AND SYSTEMS | January 2024 | June 2025 | Allow | 18 | 1 | 1 | No | No |
| 18389738 | SYSTEMS AND METHODS FOR GENETIC ENGINEERING OF A POLYPLOID ORGANISM | December 2023 | March 2025 | Allow | 15 | 1 | 1 | No | No |
| 18532727 | AUTOMATED BIOCONVERSION PROCESS FOR CONTINUOUS AND AUTOMATIC CONTROL FOR CO BIOCONVERSIONS | December 2023 | January 2025 | Allow | 13 | 2 | 0 | No | No |
| 18529216 | METHODS FOR PRODUCING MODIFIED BACTERIA FOR PRODUCTION OF NITROAROMATICS | December 2023 | February 2025 | Allow | 14 | 2 | 0 | No | No |
| 18522203 | METHOD FOR PREPARING (S)-NICOTINE BY REDUCTION | November 2023 | February 2025 | Allow | 14 | 1 | 0 | No | No |
| 18516805 | YEAST EXPRESSING A HETEROLOGOUS TREHALASE FOR ETHANOL PRODUCTION | November 2023 | May 2025 | Allow | 18 | 2 | 1 | No | No |
| 18515787 | Compositions for Facilitating the Removal of a Fingerprint | November 2023 | October 2024 | Allow | 11 | 1 | 0 | No | No |
| 18492525 | COMPOSITIONS COMPRISING A LOW pH ALPHA-AMYLASE AND A THERMOSTABLE PROTEASE FOR LIQUEFACTION | October 2023 | October 2024 | Allow | 11 | 1 | 0 | No | No |
| 18485955 | GENERATION OF PEROXYHYDROXYCARBOXYLIC ACID AND THE USE THEREOF | October 2023 | March 2025 | Allow | 17 | 1 | 1 | No | No |
| 18484322 | YEAST EXPRESSING A HETEROLOGOUS PHOSPHOLIPASE FOR ETHANOL PRODUCTION | October 2023 | April 2025 | Allow | 18 | 2 | 1 | No | No |
| 18374536 | PROCESS FOR THE PREPARATION OF 2,4- OR 2,5-PYRIDINEDICARBOXYLIC ACID AND COPOLYMERS DERIVED THEREFROM | September 2023 | June 2025 | Allow | 21 | 2 | 1 | No | No |
| 18469388 | POLYPEPTIDES HAVING LYSOZYME ACTIVITY, POLYNUCLEOTIDES ENCODING SAME AND USES AND COMPOSITIONS THEREOF | September 2023 | September 2024 | Allow | 12 | 1 | 1 | No | No |
| 18368369 | UDP-GLYCOSYLTRANSFERASE VARIANTS AND USES THEREOF | September 2023 | April 2024 | Allow | 7 | 0 | 0 | No | No |
| 18465305 | PROCESSES FOR REDUCING LACTIC ACID IN A BIOFUEL FERMENTATION SYSTEM AND PROCESSES FOR PRODUCING A FERMENTATION PRODUCT | September 2023 | November 2024 | Allow | 14 | 2 | 0 | No | No |
| 18465856 | METHODS AND COMPOSITIONS OF A FOLLICLE STIMULATING HORMONE RECEPTOR IMMUNORECEPTOR OR CHIMERIC ANTIGEN RECEPTOR | September 2023 | June 2025 | Abandon | 21 | 1 | 1 | No | No |
| 18463923 | Modified Bidirectional Catalase Promoter from Bacillus | September 2023 | May 2025 | Allow | 20 | 2 | 1 | No | No |
| 18449107 | METHODS OF cDNA PREPARATION | August 2023 | October 2024 | Allow | 14 | 1 | 1 | No | No |
| 18348544 | MODIFIED REVERSE TRANSCRIPTASES | July 2023 | October 2024 | Allow | 15 | 1 | 1 | Yes | No |
| 18217021 | HETEROLOGOUS EXPRESSION OF SHORT-CHAIN MONOOXYGENASES IN MICROORGANISMS | June 2023 | June 2025 | Allow | 24 | 2 | 1 | No | No |
| 18344244 | Food Composition Comprising L-Fucose | June 2023 | June 2025 | Allow | 24 | 2 | 1 | No | No |
| 18330944 | SYNTHESIS OF ISOPRENOIDS AND DERIVATIVES | June 2023 | March 2025 | Allow | 22 | 1 | 1 | No | No |
| 18330457 | YEAST CELLS GENETICALLY MODIFIED FOR DOWNREGULATION OF PYRUVATE DECARBOXYLASE ACTIVITY AND FBP-SENSITIVE PYRUVATE KINASE | June 2023 | April 2025 | Allow | 23 | 2 | 1 | No | No |
| 18327433 | BIOACTIVE PROTEIN-POLYMER COMPOSITIONS FOR STAIN REMOVAL | June 2023 | June 2024 | Allow | 13 | 1 | 0 | No | No |
| 18326495 | CHEMOAUTOTROPHIC CELLS COMPRISING AN ENGINEERED CARBON FIXATION PATHWAY | May 2023 | January 2025 | Abandon | 20 | 2 | 1 | No | No |
| 18199575 | LYSOSOMAL ENZYMES MODIFIED BY CELL BASED GLYCOENGINEERING | May 2023 | February 2025 | Allow | 21 | 2 | 1 | No | No |
| 18317588 | COMPOSITIONS AND METHODS FOR METABOLIC CONTROL OF A BIOFERMENTATION PROCESS WITH SYNTHETIC METABOLIC VALVES | May 2023 | October 2024 | Allow | 17 | 2 | 0 | No | No |
| 18144378 | RECOMBINANT HOST CELLS AND METHODS FOR THE PRODUCTION OF ISOBUTYRIC ACID | May 2023 | October 2024 | Abandon | 17 | 0 | 1 | No | No |
| 18311592 | COMPOSITIONS AND METHODS FOR IMPROVING MECHANICAL PROPERTIES OF A TISSUE OR FOR REGENERATING AN INJURED OR DISEASED TISSUE | May 2023 | January 2025 | Allow | 21 | 2 | 0 | No | No |
| 18141132 | MICROCROP-DERIVED ELECTROLYTE DRINK, DRIED BASE POWDER, AND MILK, AND METHODS FOR GENERATING THE SAME | April 2023 | August 2024 | Abandon | 15 | 1 | 0 | No | No |
| 18302043 | METHODS OF DECREASING THE GALACTOSE CONTENT OF A RECOMBINANT GLYCOPROTEIN EXPRESSED IN CHO CELLS | April 2023 | October 2024 | Allow | 18 | 2 | 1 | No | No |
| 18302506 | STABILIZED ENDOGLUCANASE VARIANTS | April 2023 | June 2024 | Allow | 14 | 1 | 1 | No | No |
| 18299638 | WET MILLING PROCESS | April 2023 | February 2024 | Allow | 11 | 1 | 0 | No | No |
| 18298851 | Exogenous Ketone Blend Compositions for Delivery of Ketone Bodies | April 2023 | March 2024 | Allow | 11 | 2 | 0 | No | No |
| 18295101 | THERMOPHILIC DNA POLYMERASE MUTANTS | April 2023 | May 2024 | Abandon | 13 | 1 | 0 | No | No |
| 18188061 | METHODS FOR ORGANIC ACID PRODUCTION | March 2023 | March 2024 | Allow | 12 | 1 | 1 | Yes | No |
| 18184198 | METHODS AND COMPOSITIONS FOR PRODUCING VITAMIN K DEPENDENT PROTEINS | March 2023 | August 2024 | Abandon | 17 | 1 | 0 | No | No |
| 18180711 | ENGINEERED PROLINE HYDROXYLASE BIOCATALYSTS FOR HYDROXYLATION OF CHEMICAL COMPOUNDS | March 2023 | December 2024 | Allow | 22 | 1 | 1 | Yes | No |
| 18115846 | ENABLING CHOLESTEROL CATABOLISM IN MAMMALIAN CELLS LACKING SAME | March 2023 | May 2025 | Allow | 26 | 2 | 1 | Yes | No |
| 18114051 | COMPOSITIONS FOR FACILITATING BIOLOGICAL STAIN REMOVAL | February 2023 | September 2024 | Allow | 19 | 2 | 1 | Yes | No |
| 18166975 | PROCESS OF RECOVERING OIL | February 2023 | December 2023 | Allow | 10 | 2 | 0 | No | No |
| 18152329 | MODIFIED BACTERIA FOR PRODUCTION OF NITROAROMATICS | January 2023 | September 2023 | Allow | 8 | 0 | 0 | No | No |
| 18151956 | HEMP SEED PRODUCTS AND METHODS AND SYSTEMS FOR PRODUCING SAME | January 2023 | February 2024 | Allow | 13 | 2 | 1 | No | No |
| 18059929 | Chromatographic Methods for Purification of Proteins from Plasma | November 2022 | September 2023 | Allow | 9 | 2 | 0 | No | No |
| 18058283 | ACID-ALPHA GLUCOSIDASE VARIANTS AND USES THEREOF | November 2022 | February 2025 | Allow | 27 | 2 | 1 | No | No |
| 18054917 | Microorganisms and methods for producing cannabinoids and cannabinoid derivatives | November 2022 | July 2024 | Allow | 20 | 1 | 1 | No | No |
| 17985821 | Using Proteases to Control Star Activity of Restriction Enzymes | November 2022 | June 2023 | Allow | 8 | 1 | 1 | No | No |
| 18052410 | GENE DUPLICATIONS FOR CRABTREE-WARBURG-LIKE AEROBIC XYLOSE FERMENTATION | November 2022 | March 2024 | Allow | 17 | 0 | 1 | No | No |
| 18052442 | COMPOSITIONS COMPRISING IDURONATE-2-SULFATASE | November 2022 | May 2024 | Abandon | 19 | 1 | 0 | No | No |
| 18052080 | PROCESSES FOR PRODUCING ETHANOL | November 2022 | August 2023 | Allow | 9 | 1 | 0 | No | No |
| 17962229 | BIDIRECTIONAL MULTI-ENZYMATIC SCAFFOLDS FOR BIOSYNTHESIZING CANNABINOIDS | October 2022 | April 2025 | Allow | 30 | 2 | 1 | No | No |
| 17938508 | MODIFIED POLYPEPTIDE WITH ATTENUATED ACTIVITY OF CITRATE SYNTHASE AND METHOD FOR PRODUCING L-AMINO ACID USING THE SAME | October 2022 | February 2023 | Allow | 4 | 0 | 0 | No | No |
| 17917179 | ENZYMATIC DEGRADATION OF PLASTIC POLYALKENE POLYMERS BY KATG ENZYME | October 2022 | March 2025 | Abandon | 29 | 0 | 1 | No | No |
| 17936816 | POLYMERASE VARIANTS FOR TEMPLATE-INDEPENDENT ENZYMATIC NUCLEIC ACIDS SYNTHESIS AND KIT COMPRISING THE SAME | September 2022 | July 2024 | Allow | 21 | 2 | 1 | Yes | No |
| 17907538 | METHOD FOR PRODUCING RECOMBINANT HYALURONIDASE | September 2022 | April 2024 | Allow | 19 | 1 | 1 | No | No |
| 17934465 | PROCESS OF RECOVERING OIL | September 2022 | November 2023 | Allow | 14 | 2 | 1 | No | No |
| 17933675 | ENZYME COMPLEX FOR DECOMPOSING POLYETHYLENE TEREPHTHALATE AND MANUFACTURING METHOD THEREOF | September 2022 | March 2024 | Allow | 18 | 1 | 1 | No | No |
| 17823066 | Catalysis deactivated angiotensin-converting enzyme 2 (ACE2) variants and their uses | August 2022 | October 2023 | Allow | 13 | 2 | 1 | No | No |
| 17822547 | Methods for Producing Designer Esters and Assessing Alcohol Acyltransferase Specificity for Ester Biosynthesis | August 2022 | December 2024 | Allow | 28 | 2 | 1 | Yes | No |
| 17817801 | MODIFIED SLEEPING BEAUTY TRANSPOSASE POLYPEPTIDE WITH INCREASED SOLUBILITY FOR TRANSFECTION INTO CELLS AS AN ISOLATED PROTEIN | August 2022 | January 2025 | Allow | 29 | 4 | 0 | Yes | No |
| 17795657 | SOLID STABILIZED LACCASE COMPOSITIONS | July 2022 | April 2025 | Allow | 32 | 1 | 0 | No | No |
| 17873732 | METHODS FOR THE MODIFICATION OF PEPTIDES HARBORING AN N-TERMINUS GLYCINE RESIDUE | July 2022 | November 2023 | Allow | 15 | 2 | 0 | No | No |
| 17870649 | ALGAL STRAIN AND METHODS FOR PRODUCING SIMPLE SUGARS | July 2022 | November 2023 | Allow | 16 | 1 | 1 | No | No |
| 17869608 | VARIANT CANNABINOID SYNTHASES AND METHODS AND USES THEREOF | July 2022 | October 2023 | Allow | 15 | 1 | 0 | Yes | No |
| 17758770 | Method for producing lysine from microorganism and for constructing microorganism | July 2022 | June 2025 | Allow | 36 | 2 | 1 | No | No |
| 17852008 | B-FAMILY DNA POLYMERASE VARIANT AND KIT COMPRISING THE SAME | June 2022 | May 2024 | Allow | 22 | 1 | 1 | Yes | No |
| 17840140 | HIGH-THROUGHPUT ENZYME ASSAY FOR SCREENING ACTIVITY OF ACYLTRANSFERASES | June 2022 | May 2025 | Allow | 35 | 2 | 1 | Yes | No |
| 17837497 | REVERSE TRANSCRIPTASE VARIANTS | June 2022 | November 2023 | Allow | 17 | 1 | 1 | Yes | No |
| 17837832 | RECOMBINANT HOST CELLS AND METHODS FOR THE PRODUCTION OF D-LACTIC ACID | June 2022 | July 2023 | Abandon | 14 | 1 | 0 | No | No |
| 17830794 | METHODS OF ENHANCING THE SIALIC ACID CONTENT OF A CHO-EXPRESSED RECOMBINANT GLYCOPROTEIN | June 2022 | January 2023 | Allow | 8 | 1 | 0 | No | No |
| 17829866 | POLYMERASES, COMPOSITIONS, AND METHODS OF USE | June 2022 | April 2024 | Allow | 23 | 2 | 1 | Yes | No |
| 17749015 | COMPOSITIONS AND METHODS FOR THE BIOSYNTHESIS OF 1,4-BUTANEDIOL AND ITS PRECURSORS | May 2022 | May 2025 | Abandon | 36 | 0 | 1 | No | No |
| 17744782 | METHOD AMD STRAINS FOR REDUCING BYPRODUCT FUMARIC ACID IN FERMENTATION PROCESS OF L-MALIC ACID AND USE THEREOF | May 2022 | June 2023 | Allow | 13 | 2 | 1 | No | No |
| 17737389 | Method of Producing Ribulose-1,5-Bisphosphate Oxygenase Protein Fibers | May 2022 | April 2024 | Allow | 24 | 1 | 1 | No | No |
| 17774753 | STABILIZED LIQUID ENZYME COMPOSITIONS FOR BREWING | May 2022 | March 2025 | Allow | 34 | 1 | 0 | No | No |
| 17735050 | PICHIA STIPITIS STRAIN AND CULTURES AND USES OF THE SAME | May 2022 | April 2023 | Allow | 12 | 1 | 0 | No | No |
| 17755191 | HIGH-EFFICIENCY SYNTHESIS AND HIGH-PURITY HYALURONIC ACID, AND RECOMBINANT CORYNEBACTERIUM GLUTAMICUM FOR OLIGOSACCHARIDE THEREOF | April 2022 | March 2024 | Allow | 23 | 2 | 1 | Yes | No |
| 17769204 | TRANSAMINASE MUTANT AND USE THEREOF | April 2022 | May 2025 | Allow | 37 | 2 | 1 | No | No |
| 17658585 | PROCESS FOR IMPROVING CARBON CONVERSION EFFICIENCY | April 2022 | December 2024 | Abandon | 32 | 1 | 0 | No | No |
| 17713797 | PROCESSES FOR PRODUCING A FERMENTATION PRODUCT | April 2022 | June 2023 | Allow | 14 | 2 | 1 | No | No |
| 17711451 | ENGINEERED ACETATE KINASE VARIANT ENZYMES | April 2022 | October 2023 | Allow | 19 | 1 | 1 | No | No |
| 17763886 | METHOD OF PRODUCING POLYHYDROXYALKANOATE | March 2022 | January 2025 | Allow | 34 | 1 | 0 | No | No |
| 17698813 | PROMOTER VARIANTS FOR PROTEIN PRODUCTION | March 2022 | January 2024 | Allow | 22 | 2 | 0 | No | No |
| 17642925 | Processes for Producing Fermentation Products and Compositions Used therein | March 2022 | August 2024 | Allow | 29 | 2 | 1 | No | No |
| 17691029 | Polymerase-Tethered Nucleotides for Nucleic Acid Synthesis | March 2022 | November 2022 | Allow | 8 | 1 | 1 | No | No |
| 17689586 | ANAEROBIC PRECONDITIONING OF CELLS FOR IMPROVED IN VITRO PROTEIN PRODUCTION | March 2022 | June 2025 | Allow | 39 | 2 | 1 | Yes | No |
| 17638250 | EXPRESSION OF BETA-GLUCOSIDASE IN YEAST FOR IMPROVED ETHANOL PRODUCTION | February 2022 | May 2025 | Allow | 39 | 1 | 1 | No | No |
| 17678451 | GLYCEROL-FREE FORMULATIONS FOR REVERSE TRANSCRIPTASES | February 2022 | February 2024 | Allow | 24 | 1 | 1 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner FRONDA, CHRISTIAN L.
With a 66.7% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 39.6% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner FRONDA, CHRISTIAN L works in Art Unit 1652 and has examined 1,710 patent applications in our dataset. With an allowance rate of 75.7%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 26 months.
Examiner FRONDA, CHRISTIAN L's allowance rate of 75.7% places them in the 33% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by FRONDA, CHRISTIAN L receive 1.54 office actions before reaching final disposition. This places the examiner in the 39% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by FRONDA, CHRISTIAN L is 26 months. This places the examiner in the 60% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.
Conducting an examiner interview provides a +22.4% benefit to allowance rate for applications examined by FRONDA, CHRISTIAN L. This interview benefit is in the 71% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 34.2% of applications are subsequently allowed. This success rate is in the 70% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 67.6% of cases where such amendments are filed. This entry rate is in the 89% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
When applicants request a pre-appeal conference (PAC) with this examiner, 80.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 60% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 95.8% of appeals filed. This is in the 84% percentile among all examiners. Of these withdrawals, 85.3% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 66.2% are granted (fully or in part). This grant rate is in the 82% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 7.5% of allowed cases (in the 93% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 25.8% of allowed cases (in the 94% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.